The DOI matches its Crossref record; 145 of the 167 references it cites were found in a registry or an index.
Repair of O6-alkylguanine by alkyltransferases
Abstract
The predominant pathway for the repair of O(6)-methylguanine in DNA is via the activity of an alkyltransferase protein that transfers the methyl group to a cysteine acceptor site on the protein itself. This review article describes recent studies on this alkyltransferase. The protein repairs not only methyl groups but also 2-chloroethyl-, benzyl- and pyridyloxobutyl-adducts. It acts on double-stranded DNA by flipping the O(6)-guanine adduct out of the DNA helix and into a binding pocket. The free base, O(6)-benzylguanine, is able to bind in this pocket and react with the cysteine, rendering it an effective inactivator of mammalian alkyltransferases. The alkylated form of the protein is rapidly degraded by the ubiquitin/proteasomal system. Some tumor cells do not express alkyltransferase despite having an intact gene. Methylation of key sites in CpG-rich islands in the promoter region are involved in this silencing and a change in the nuclear localization of an enhancer binding protein may also contribute. The alkyltransferase promoter contains Sp1, GRE and AP-1 sites and is slightly inducible by glucocorticoids and protein kinase C activators. There is a complex relationship between p53 and alkyltransferase expression with p53 mediating a rise in alkyltransferase in response to ionizing radiation but having no clear effect on basal levels. DNA adducts at the O(6)-position of guanine are a major factor in the carcinogenic, mutagenic, apoptopic and clastogenic actions of methylating agents and chloroethylating agents. Studies with transgenic mice in which alkyltransferase levels are increased or decreased confirm the importance of this repair pathway in protecting against carcinogenesis. Alkyltransferase activity in tumors protects them from therapeutic agents such as temozolomide and BCNU. This resistance is abolished by O(6)-benzylguanine and this drug is currently in clinical trials to enhance cancer chemotherapy by these agents. Studies are in progress to reduce the toxicity of such therapy towards the bone marrow by gene therapy to express alkyltransferases with mutations imparting resistance to O(6)-benzylguanine at high levels in marrow stem cells. Several polymorphisms in the human alkyltransferase gene have been identified but the significance of these in terms of alkyltransferase action is currently unknown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The MGMT, DUSP22, CDCA2, ID2, TNFRSF1B, ZNF681, and IGSF21 may have a role in the etiology and pathogenesis of this disease.[31][32][33][34][35][36][37][38][39][40]”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [32]
Citations
Cites
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
Pegg, A. E. (1990) · PubMed · Cited by 734
Self-citationREGULATION AND EXPRESSION OF THE ADAPTIVE RESPONSE TO ALKYLATING AGENTS
Lindahl, T. L., Sedgwick, B., Sekiguchi, M., & Nakabeppu, Y. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001025 · Cited by 650
Structure, Function, and Inhibition of O6-Alkylguanine-DNA Alkyltransferase
Pegg, A. E., Dolan, M. E., & Moschel, R. C. (1995) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60879-x · Cited by 506
Self-citationParikh, S. S., Mol, C. D., Slupphaug, G., Bharati, S., Krokan, H. E., & Tainer, J. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5214 · Cited by 497
Roberts, R. J., & Cheng, X. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.181 · Cited by 315
Jaeckle, K. A., Eyre, H. J., Townsend, J. J., Schulman, S., Knudson, H. M., Belanich, M., Yarosh, D. B., Bearman, S., Giroux, D. J., & Schold, S. C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3310 · Cited by 297
Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis
D’Atri, S., Tentori, L., Lacal, P. M., Graziani, G., Pagani, E., Benincasa, E., Zambruno, G., Bonmassar, E., & Jiricny, J. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.334 · Cited by 282
Repair of DNA containing O 6 ‐alkylguanine
Pegg, A. E., & Byers, T. L. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.6.1544541 · Cited by 244
Self-citationSrivenugopal, K. S., Yuan, X., Friedman, H. S., & Ali‐Osman, F. (1996) · Biochemistry · doi:10.1021/bi9518205 · Cited by 218
Research works printed but not linked: 6
- Kaur, 1999, Role of the O6-alkylguanine DNA alkyltransferase codons 143 and 160 polymorphisms in lung cancer risk, Proc. Am. Assoc. Cancer Res., 40, A1646
- Egyhazi, 1999, Novel polymorphisms in the O6-methylguanine DNA methyltransferase gene in human melanoma, Proc. Am. Assoc. Cancer Res., 40, A3093
- Crone, 1999, Ubiquitin-mediated proteolysis of O6-alkylguanine-DNA alkyltransferase following inactivation with O6-benzylguanine, Proc. Am. Assoc. Cancer Res., 40, A2656
- Herfath, 1999, A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers, Mol. Carcinog., 24, 90, 10.1002/(SICI)1098-2744(199902)24:2<90::AID-MC3>3.0.CO;2-B · DOI
- Middleton, 1999, O6-(4-Bromothenyl)-guanine is an effective inactivator of O6-alkylguanine-DNA alkyltransferase, and improves the therapeutic index of temozolomide to a greater extent than O6-benzylguanine, Proc. Am. Assoc. Cancer Res., 40, A39
- Friedman, 1999, The biology of sensitivity and resistance to the molecule (temozolomide), Proc. Am. Assoc. Cancer Res., 40, 754
Cited by
Sorted by citations
Items 301–400 of 576
Noll, D. M., & Clarke, N. D. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.19.4025 · Cited by 19
Aging and cancer in transgenic and mutant mice
Anisimov, V. N. (2003) · Frontiers in bioscience · doi:10.2741/1122 · Cited by 19
“O(6)-methylguanine-DNA methyltransferase (MGMT) transgenic mice The DNA repair enzyme MGMT is a suicide acceptor protein that removes alkyl groups from the O(6) position of guanine alkylated by potent carcinogen nitroso compounds (220).”
BackgroundRecent therapeutic advances and insights of recurrent glioblastoma multiforme
Chen, J. (2012) · Frontiers in bioscience · doi:10.2741/4130 · Cited by 18
McManus, F. P., Khaira, A., Noronha, A. M., & Wilds, C. J. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300553u · Cited by 18
Detecting DNA Methylation Using Surface-Enhanced Raman Spectroscopy
Hasan, S. M. A., He, Y., Chang, T.-W., Wang, J., & Gartia, M. R. (2018) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.8b10178 · Cited by 18
Fix, D. F., Canugovi, C., & Bhagwat, A. S. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.04.008 · Cited by 18
“methyltransferases, which transfer the alkyl group from the affected base to a cysteine residue within the protein [3].”
BackgroundImaging Genomics of Glioblastoma
Moton, S., Elbanan, M., Zinn, P. O., & Colen, R. R. (2015) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000052 · Cited by 18
Pegg, A. E., Goodtzova, K., Loktionova, N. A., Kanugula, S., Pauly, G. T., & Moschel, R. C. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38839-1 · Cited by 18
“…G itself is that the former was able to inactivate mutant forms of the AGT protein that are highly resistant to b 6 G. Detailed studies have indicated that there are many sites at which such resistance can be produced by point mutations (Xu-Welliver et al., 1998, 1999; Xu-Welliver and Pegg, 2000).”
Self-citationJuillerat, A., & Juillerat‐Jeanneret, L. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.3.349 · Cited by 18
“Many analogs of O6-benzylguanine have been prepared, mainly improving their solubility, biological stability and inhibitory potency [13,52].”
BackgroundNieto, Y. L. (2003) · Cancer chemotherapy and biological response modifiers · doi:10.1016/s0921-4410(03)21008-5 · Cited by 18
USP7 promotes temozolomide resistance by stabilizing MGMT in glioblastoma
Li, J., Feng, X., Liu, Z., Deng, Y., Sun, Z., Chen, B., Wu, L., Wang, X., Miao, L., Zeng, L., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07969-3 · Cited by 17
Nakai, K., Mitomi, H., Yimit, A., Arakawa, A., Yao, T., Tokuda, E., Saito, M., & Kasumi, F. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1777-7 · Cited by 17
McManus, F. P., O’Flaherty, D. K., Noronha, A. M., & Wilds, C. J. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob25705j · Cited by 17
Merlo, R., Prete, S. D., Valenti, A., Mattossovich, R., Carginale, V., Supuran, C. T., Capasso, C., & Perugino, G. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1559161 · Cited by 17
Differential inactivation of polymorphic variants of human O6-alkylguanine-DNA alkyltransferase
Fang, Q., Loktionova, N. A., Moschel, R. C., Javanmard, S., Pauly, G. T., & Pegg, A. E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.022 · Cited by 17
“DNA adducts at the O6-position of guanine are important for the antitumor action of a number of drugs including the methylating agents, temozolomide, procarbazine and dacarbazine, and the chloroethylating agents, BCNU and CCNU [1-4].”
BackgroundSelf-citationGeoerger, B., Vassal, G., Doz, F., O’Quigley, J., Wartelle, M., Watson, A. J., Raquin, M., Frappaz, D., Chastagner, P. B., Gentet, J. C., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602740 · Cited by 16
“…of guanine and the mismatch repair system, and is inversely related to the activity of the DNA repair protein O6-AlkyguanineDNA alkyltransferase (also known as O6-methylguanine-DNA methyltransferase (MGMT)) (Karran and Hampson, 1996; Pegg, 2000; Gerson, 2002; Tentori and Graziani, 2002).”
BackgroundFogli, A., Chautard, E., Vaurs‐Barrière, C., Pereira, B., Müller-Barthélémy, M., Court, F., Biau, J., Pinto, A. A., Kémény, J., Khalil, T., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv251 · Cited by 16
Ren, X., Li, H., Song, X., Wu, Y., & Liu, Y. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s162381 · Cited by 16
Ye, L., He, Z., Li, D., Chen, L., Chen, S., Guo, P., Yu, D., Ma, L., Niu, Y., Duan, H., et al. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128538 · Cited by 17
Zheng, Q., Liu, X., Fei, X., Wang, J.-Q., Ohannesian, D. W., Erickson, L. C., Stone, K. L., Martinez, T. D., Miller, K. D., & Hutchins, G. D. (2002) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.636 · Cited by 16
Trabelsi, S., Mama, N., Ladib, M., Karmeni, N., Mastouri, M. H., Chourabi, M., Mokni, M., Tlili, K., Krifa, H., Yacoubi, M. T., et al. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1381-0 · Cited by 15
Pandith, A. A., Qasim, I., Baba, S. M., Koul, A. M., Zahoor, W., Afroze, D., Lateef, A., Manzoor, U., Bhat, I. A., Sanadhya, D., et al. (2020) · Future Science OA · doi:10.2144/fsoa-2020-0057 · Cited by 19
Kurdi, M. E., Butt, N. S., Baeesa, S. S., Alghamdi, B. S. A., Maghrabi, Y., Bardeesi, A. M., Saeedi, R., Alsinani, T., Alghanmi, N. M., Bari, M. O., et al. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.1609778 · Cited by 15
“The MGMT, which is a DNA repair protein that removes alkyl groups from several residues particularly the O6-position of guanine, is considered the most relevant for the action of an extensively used TMZ [7, 8].”
BackgroundSite-specifically modified fusion proteins for molecular imaging
Wang, H. (2007) · Frontiers in bioscience · doi:10.2741/2795 · Cited by 15
A novel protein, MAPO1, that functions in apoptosis triggered by O6-methylguanine mispair in DNA
Komori, K., Takagi, Y., Sanada, M., Lim, T.-H., Nakatsu, Y., Tsuzuki, T., Sekiguchi, M., & Hidaka, M. (2009) · Oncogene · doi:10.1038/onc.2008.462 · Cited by 15
Classical and Targeted Anticancer Drugs: An Appraisal of Mechanisms of Multidrug Resistance
Baguley, B. C. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3347-1_2 · Cited by 15
The response to the DNA damaging agent methyl methanesulfonate in a fungal plant pathogen
Milo, S., Pareek, M., Delulio, G., Almog, Y., Anand, G., Ma, L., & Covo, S. (2019) · Fungal Biology · doi:10.1016/j.funbio.2019.03.007 · Cited by 15
Sputum-Based Molecular Biomarkers for the Early Detection of Lung Cancer: Limitations and Promise
Kim, C. E., Tchou-Wong, K.-M., & Rom, W. N. (2011) · Cancers · doi:10.3390/cancers3032975 · Cited by 16
“MGMT rapidly reverses alkylation, including methylation, at the O position of guanine by transferring the alkyl group to the active site of the enzyme [36].”
BackgroundPovey, A. C., O’Donnell, E., Barber, P. V., Watson, M., Margison, G. P., & Santibanez‐Koref, M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21790 · Cited by 15
Heighway, J. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg124 · Cited by 15
Genetic analysis to complement histopathological diagnosis of brain tumors.
Nakamura, M., Shimada, K., Ishida, E., Nakase, H., & Konishi, N. (2007) · PubMed · doi:10.14670/hh-22.327 · Cited by 15
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis
Menigatti, M., Pedroni, M., Verrone, A., Borghi, F., Scarselli, A., Benatti, P., Losi, L., Gregorio, C. D., Schär, P., Marra, G., et al. (2007) · Oncology Reports · doi:10.3892/or.17.6.1421 · Cited by 15
“MGMT protects cells from the mutagenic and cytotoxic effects of environmental alkylating carcinogens by transferring the mutagenic methyl group from the O6position of guanine to a cysteine residue at its active site (18).”
BackgroundSingh, S., Nema, R., Banerjee, M., & Kushwah, A. S. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002335 · Cited by 14
Hegde, M. M., Palkar, P., Mutalik, S. P., Mutalik, S., Goda, J. S., & Rao, B. S. S. (2024) · 3 Biotech · doi:10.1007/s13205-024-04123-2 · Cited by 19
“…small molecule that can easily pass through the BBB. O6-BG O6-BG acts as a pseudosubstrate by adding a benzyl group to the cysteine 145 residue of the MGMT active site, thereby inactivating MGMT and preventing the removal of methyl groups from DNA (Bobola et al. 2005; Koch et al. 2007; Pegg 2000).”
BackgroundWyatt, M. D. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00002-2 · Cited by 14
Every OGT Is Illuminated … by Fluorescent and Synchrotron Lights
Miggiano, R., Valenti, A., Rossi, F., Rizzi, M., Perugino, G., & Ciaramella, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122613 · Cited by 14
Kaina, B., Izzotti, A., Xu, J., Christmann, M., Pulliero, A., Zhao, X., Dobreanu, M., & Au, W. W. (2018) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2018.07.003 · Cited by 14
Mutations That Probe the Cooperative Assembly of O6-Alkylguanine-DNA Alkyltransferase Complexes
Adams, C., & Fried, M. G. (2011) · Biochemistry · doi:10.1021/bi101970d · Cited by 14
“While this activity protects normal cells from alkylating agents, it also protects tumor cells against chemotherapeutic drugs that alkylate DNA (5,6).”
BackgroundPhotoactivatable Reaction for Covalent Nanoscale Patterning of Multiple Proteins
Zhou, S., Metcalf, K. J., Bugga, P., Grant, J. L., & Mrksich, M. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b16736 · Cited by 14
Nguyen, Q. N., Vuong, L. D., Truong, V., Ta, T. V., Nguyen, N. T., Nguyen, H. P., & Hà, C. H. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.01.032 · Cited by 14
Shukla, P. K., & Mishra, P. (2009) · Physical Chemistry Chemical Physics · doi:10.1039/b908295f · Cited by 14
Liu, X., Zheng, Q., Fei, X., Wang, J.-Q., Ohannesian, D. W., Erickson, L. C., Stone, K. L., & Hutchins, G. D. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01048-x · Cited by 14
Fujikane, R., Sanada, M., Sekiguchi, M., & Hidaka, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044817 · Cited by 13
“To preserve genome integrity from the mutagenic insult, organisms possess a specific repair protein, O(6)-methylguanine-DNA methyltransferase (MGMT), which transfers a methyl group from O(6)-methylguanine to a methyl-acceptor cysteine residue in the molecule [6,7,8].”
BackgroundProtein-based tumor molecular imaging probes
Lin, X., Xie, J., & Chen, X. S. (2010) · Amino Acids · doi:10.1007/s00726-010-0545-z · Cited by 13
“It was demonstrated previously that hAGT have a very broad substrate specificity and can act at on a very wide range of benzylguanine groups (Margison and Santibanez-Koref 2002; Pegg 2000).”
Genetic Association Between Angiotensinogen Polymorphisms and Lung Cancer Risk
Wang, H., Zhang, K., Qin, H., Yang, L., Zhang, L., & Cao, Y. (2015) · Medicine · doi:10.1097/md.0000000000001250 · Cited by 13
Mattossovich, R., Merlo, R., Miggiano, R., Valenti, A., & Perugino, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082878 · Cited by 13
“The interest shown from the important insights of this class of small proteins led to novel biotechnological applications [101].”
BackgroundDirect Alkylation of Deoxyguanosine by Azaserine Leads to O6-Carboxymethyldeoxyguanosine
Geisen, S. M., Aloisi, C. M. N., Huber, S. M., Sandell, E. S., Escher, N. A., & Sturla, S. J. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00471 · Cited by 13
Shimada, Y., Nishimura, M., Kakinuma, S., Ogiu, T., Fujimoto, H., Kubo, A., Nagai, J., KOBAYASH, K., Tano, K., Yoshinaga, S., et al. (2003) · International Journal of Radiation Biology · doi:10.1080/0955300031000139371 · Cited by 13
“A possible relationship between the polymorphic difference, AGT activity and cancer risks has been reported (Deng et al. 1999, Pegg 2000).”
BackgroundPapel das proteínas XPD e DNA polimerase eta nas respostas de células humanas a danos no genoma
Lerner, L. K. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-20102014-103732 · Cited by 13
S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver
Leung, J., Wei, W., & Liu, L. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt031 · Cited by 12
“formed endogenously [21-23].”
Morimoto, T., Mitomi, H., Saito, T., Takahashi, M., Murakami, T., Sakamoto, N., Yao, T., & Watanabe, S. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12553 · Cited by 12
Alkyltransferase-mediated toxicity of bis-electrophiles in mammalian cells
Kalapila, A. G., & Pegg, A. E. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.11.006 · Cited by 12
Self-citationAdema, A. D., van der Born, K., Honeywell, R. J., & Peters, G. J. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.3.338 · Cited by 12
O’Flaherty, D. K., & Wilds, C. J. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201501103 · Cited by 12
Relationship between promoter methylation & tissue expression of MGMT gene in ovarian cancer.
Shilpa, V., Bhagat, R., Premalata, C. S., Pallavi, V. R., Ramesh, G., & Krishnamoorthy, L. (2014) · Europe PMC (PubMed Central) · Cited by 12
Immunohistochemical Assessment of MGMT Expression and p53 Mutation in Glioblastoma Multiforme
Lotfi, M., Afsharnezhad, S., Raziee, H., Ghaffarzadegan, K., Sharif, S., Shamsara, J., Lary, S., & Behravan, J. (2011) · Tumori Journal · doi:10.1177/030089161109700118 · Cited by 12
Lamb, K. L., Liu, Y., Ishiguro, K., Kwon, Y., Paquet, N., Sartorelli, A. C., Sung, P., Rockwell, S., & Sweasy, J. B. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21964 · Cited by 12
Ekim, M., Caner, V., Büyükpınarbaşılı, N., Tepeli, E., Elmas, L., & Bağcı, G. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0211 · Cited by 12
“It has been reported that the frequency of promoter methylation of MGMT was increased in a variety of human cancers, including lung cancer (Pegg, 2000; Esteller, 2007; Jacinto and Esteller, 2007).”
O6-methylguanine-DNA methyltransferase (MGMT): Can function explain a suicidal mechanism?
Gouws, C., & Pretorius, P. J. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.07.055 · Cited by 12
Rhee, J., Kim, R., Chang, H., Lee, J., Lee, Y.-M., & Lee, J.-S. (2010) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2010.10.005 · Cited by 12
Krajnović, M., Jovanović, M. P., Mihaljević, B., Anđelić, B., Tarabar, O. T., Ušaj, S. K., & Krtolica, K. (2014) · Clinical and Translational Science · doi:10.1111/cts.12162 · Cited by 12
Matsuda, S., Mafune, A., Kohda, N., Hama, T., & Urashima, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231932 · Cited by 12
Al-Obaide, M. A. I., Arutla, V., Bacolod, M. D., Wang, W., Zhang, R., & Srivenugopal, K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052492 · Cited by 12
“Both the antimutagenic and drug resistance properties conferred by MGMT derive from its ability to remove the alkyl groups from the O6-position in the DNA to cysteine 145 at the active site in a unique suicidal reaction [1,2,5].”
BackgroundFontes, A. M., Davis, B. M., Encell, L. P., Lingas, K. T., Covas, D. T., Zago, M. A., Loeb, L. A., Pegg, A. E., & Gerson, S. L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0236 · Cited by 12
“because large numbers of adducts are formed, and removal of most of these adducts is required to protect the cell (27).”
BackgroundSelf-citationWestekemper, H., Freistuehler, M., Anastassiou, G., Nareyeck, G., Bornfeld, N., Steuhl, K., Scheulen, M. E., & Hilger, R. A. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300686 · Cited by 12
“DNA repair by the O6-methylguanine-DNA methyltransferase (MGMT) is involved in drug resistance to methylating drugs and therapeutic agents with similar characteristics.(29) We have not examined the underlying mechanism of the resistance of the conjunctival melanoma cell lines to fotemustine, but it may be connected wi…”
BackgroundA Convenient Procedure for the Synthesis of O6-Benzylguanine Derivatives by Phase Transfer Catalysis
Liu, X., Zheng, Q., Hutchins, G. D., Fei, X., Erickson, L. C., Miller, K. D., Mock, B. H., Glick‐Wilson, B. E., Winkle, W. L., Stone, K. L., et al. (2003) · Synthetic Communications · doi:10.1081/scc-120016358 · Cited by 12
Kotandeniya, D., Murphy, D., Seneviratne, U. I., Guza, R., Pegg, A. E., Kanugula, S., & Tretyakova, N. Y. (2011) · Chemical Research in Toxicology · doi:10.1021/tx2002993 · Cited by 11
Self-citationDRUG RESISTANCE PATHWAYS AS TARGETS
Tomida, A., & Tsuruo, T. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50006-1 · Cited by 11
Serpe, M., Forenza, C., Adamo, A., Russo, N., Perugino, G., Ciaramella, M., & Valenti, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-43394-1 · Cited by 11
Guo, J., Yi, G., Liu, Z., Sun, X., Yang, R., Guo, M., Li, Y., Li, K., Li, K., Wang, X., et al. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3459 · Cited by 11
Effect of O6‐alkylguanine‐DNA alkyltransferase on genotoxicity of epihalohydrins
Kalapila, A. G., Loktionova, N. A., & Pegg, A. E. (2009) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20491 · Cited by 11
“N IH -PA A uth or M an uscript N IH -PA A uth or M an uscript (Pegg, 2000; Margison and Santibáñez-Koref, 2002; Margison et al., 2003; Tubbs et al., 2007).”
BackgroundSelf-citationKramer, B., Lemckert, F. A., Alexander, I. E., Gunning, P. W., & McCowage, G. B. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.937 · Cited by 11
State of the art chemotherapeutic management of pediatric brain tumors
Siegel, M. J., Finlay, J. L., & Zacharoulis, S. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.5.765 · Cited by 11
Yamauchi, T., Kawai, Y., & Ueda, T. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00412-x · Cited by 11
Genomic Instability and DNA Repair
Kohn, K. W., & Bohr, V. A. (2005) · Wiley eBooks · doi:10.1002/0470025077.chap07 · Cited by 11
Chen, Y., Qu, W., Tu, J., & Qi, H. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2809197 · Cited by 10
Xu, M., Cross, C. E., Speidel, J. T., & Abdel‐Rahman, S. Z. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0286-4 · Cited by 10
Ming, X., Michaelson-Richie, E. D., Groehler, A. S., Villalta, P. W., Campbell, C., & Tretyakova, N. Y. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102840 · Cited by 10
“AGT is an important DNA repair protein that removes promutagenic DNA O6-alkylguanine lesions formed as a result of exposure to chemotherapeutic drugs and environmental toxins [36].”
BackgroundEda, T., Okada, M., Ogura, R., Tsukamoto, Y., Kanemaru, Y., Watanabe, J., On, J., Aoki, H., Oishi, M., Takei, N., et al. (2022) · Cancers · doi:10.3390/cancers14030770 · Cited by 10
“In TMZ-based chemotherapy, where DNA mismatch and subsequent apoptosis occurs, resistance has been associated with MGMT expression [40].”
BackgroundCastro, G. N., Cayado-Gutiérrez, N., Moncalero, V. L., Lima, P., Angelis, R. L. D., Chávez, V., Cuello-Carrión, F. D., & Ciocca, D. R. (2012) · Cell Stress and Chaperones · doi:10.1007/s12192-012-0350-6 · Cited by 10
“MGMT expression has a central role in resistance to alkylating agents such as temozolomide, and it is an ideal potential target for biochemical modulation of drug resistance (Bignami et al. 2000; Pegg 2000; Gerson 2004).”
BackgroundHorii, J., Hiraoka, S., Kato, J., Saito, S., Harada, K., Fujita, H., Kaji, E., & Yamamoto, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01140.x · Cited by 10
Kanchan, S., Mehrotra, R., & Chowdhury, S. (2014) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-014-0070-1 · Cited by 9
“Our analysis has also identified helix-turn-helix AraC domain and Ada_Zn_binding domains within MGMT protein of E. coli which is deleted during course of evolution.”
InfluentialDirect Reversal Repair in Mammalian Cells
Ahmad, A., Nay, S. L., & O'Connor, T. R. (2015) · InTech eBooks · doi:10.5772/60037 · Cited by 8
Лукаш, Л. Л. (2004) · Biopolymers and Cell · doi:10.7124/bc.000697 · Cited by 9
Le, D.-V., Zhou, D.-M., Tang, L., Jiang, J., Yu, R., & Wang, Y. (2013) · Analytica Chimica Acta · doi:10.1016/j.aca.2013.10.036 · Cited by 9
Lesion-specific DNA-binding and repair activities of human O6-alkylguanine DNA alkyltransferase
Melikishvili, M., & Fried, M. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks674 · Cited by 9
Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients
Cellarier, E., Terret, C., Labarre, P., Ouabdesselam, R., Curé, H., Marchenay, C., Maurizis, J. C., Madelmont, J., Chollet, P. J. M., & Armand, J. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf098 · Cited by 9
Martínez‐Ramírez, O. C., Pérez–Morales, R., Hernández, C. C., Gonsebatt, M. E., Casas-Ávila, L., Valdés‐Flores, M., Petrosyan, P., de León-Suárez, V. P., & Rubio, J. (2019) · DNA and Cell Biology · doi:10.1089/dna.2018.4526 · Cited by 9
“…7-methyguanine and O 6 -methylguanine (MeG), this being one of the promutagenic DNA adducts that causes [G:C]A:T mutations during DNA replication (Kaina et al. , 2007; Ensminger et al. , 2014), MeG can be removed only by the enzyme O 6 -methylguanine-DNA methyltransferase (MGMT) (Pegg, 2000).”
ETHANOL MODULATES RAT HEPATIC DNA REPAIR FUNCTIONS
Navasumrit, P. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.5.369 · Cited by 9
Silence Is Golden: Gene Hypermethylation and Survival in Large-Cell Lymphoma
Dolan, M. E. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.1.6 · Cited by 9
“MGMT is a unique protein that removes O6-guanine adducts from DNA, thereby restoring the original DNA in a single step (5, 6 ).”
BackgroundKotandeniya, D., Murphy, D., Yan, S., Park, S., Seneviratne, U. I., Koopmeiners, J. S., Pegg, A. E., Kanugula, S., Kassie, F., & Tretyakova, N. Y. (2013) · Biochemistry · doi:10.1021/bi4004952 · Cited by 8
Self-citationLe, D.-V., & Jiang, J. (2020) · Microchimica Acta · doi:10.1007/s00604-020-04280-0 · Cited by 8
Abril, N., Luque-Romero, F. L., Yamada, M., Nohmi, T., & Pueyo, C. (2001) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00235-2 · Cited by 8
Petrella, M., Montaner, J., Batist, G., & Wainberg, M. A. (2004) · Cancer Investigation · doi:10.1081/cnv-120027590 · Cited by 8
Lee, G., Kang, J.-H., Kim, I., Kim, H., Ko, G. H., Lee, J. H., Kim, D. C., Song, D. H., Yang, J. W., & Lee, J. S. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903312462 · Cited by 8
Methods for Measuring DNA Repair: Introduction and Cellular Repair
Collins, A. R., & Azqueta, A. (2014) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-1068-7_21 · Cited by 8
Song, X., Xie, L., Chang, M., Wang, X., Wang, X., Chen, T. C., & Song, X. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0193-2 · Cited by 9
Clinical Trials Using LV-P140K-MGMT for Gliomas
Lin, Y., & Gerson, S. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394295-1.00026-3 · Cited by 8
Álvarez, L., Comendador, M. A., & Sierra, L. M. (2003) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10149 · Cited by 8
“In mammals, O6-alkylguanine is repaired by the cooperative rather than the additive action of NER and the protein O6-methylguanine-DNA methyltransferase (MGMT) [Bronstein et al., 1992], which plays an important role in alkylation damage repair in all kinds of organisms [Pegg, 2000].”
BackgroundAbdu, K., Aiertza, M. K., Wilkinson, O. J., Grasby, J. A., Senthong, P., Povey, A. C., Margison, G. P., & Williams, D. M. (2012) · Chemical Communications · doi:10.1039/c2cc36252j · Cited by 7
Metadata
- Authors
- Pegg, A. E.
- Affiliations
- Pennsylvania State University (US)
- Corresponding author
- Pegg, Anthony E
- Venue
- Mutation Research/Reviews in Mutation Research
- Publisher
- Elsevier BV
- Published
- 2000-04
- Volume
- 462
- Issue
- 2-3
- Pages
- 83-100
- ISSN
- 1383-5742 (ISSN-L)
- OpenAlex
- W1999549596
- Cited by
- 576
- References
- 167
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 16 · 2023: 12 · 2022: 11 · 2021: 10 · 2020: 15 · 2019: 17 · 2018: 13 · 2017: 14 · 2016: 16 · 2015: 21 · 2014: 30 · 2013: 36 · 2012: 26
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Mutation Research/Reviews in Mutation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA57725, CA-18137, R01CA071976, CA 71976)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- O6-alkylguanine, alkyltransferase, DNA repair, O6-methylguanine, O6-benzylguanine, alkylating agents, ubiquitin-proteasome degradation, promoter methylation, gene silencing, p53, temozolomide resistance, transgenic mice, myelosuppression
- MeSH terms
- Animals, DNA Repair, Guanine, Humans, DNA Adducts, Alkyl and Aryl Transferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review